Abstract
Axons are diverse. They have different lengths, different branching patterns, and different biological roles. Methods to study axon degeneration are also diverse. The result is a bewildering range of experimental systems in which to study mechanisms of axon degeneration, and it is difficult to extrapolate from one neuron type and one method to another. The purpose of this chapter is to help readers to do this and to choose the methods most appropriate for answering their particular research question.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Conforti L, Gilley J, Coleman MP (2014) Wallerian degeneration: an emerging axon death pathway linking injury and disease. Nat Rev Neurosci 15:394–409. https://doi.org/10.1038/nrn3680
Van Helleputte L, Kater M, Cook DP et al (2018) Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth. Neurobiol Dis 111:59–69. https://doi.org/10.1016/j.nbd.2017.11.011
Corey DR (2017) Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy. Nat Neurosci 20:497–499. https://doi.org/10.1038/nn.4508
Matsuda W, Furuta T, Nakamura KC et al (2009) Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal Arborizations in the Neostriatum. J Neurosci 29:444–453. https://doi.org/10.1523/JNEUROSCI.4029-08.2009
Gilley J, Coleman MP (2010) Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol 8:e1000300. https://doi.org/10.1371/journal.pbio.1000300
Nichols ALA, Meelkop E, Linton C et al (2016) The apoptotic engulfment machinery regulates axonal degeneration in C. elegans neurons. Cell Rep 14:1673–1683. https://doi.org/10.1016/j.celrep.2016.01.050
Mack TGA, Reiner M, Beirowski B et al (2001) Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci 4:1199–1206. https://doi.org/10.1038/nn770
Adalbert R, Gillingwater TH, Haley JE et al (2005) A rat model of slow Wallerian degeneration ( WldS ) with improved preservation of neuromuscular synapses. Eur J Neurosci 21:271–277. https://doi.org/10.1111/j.1460-9568.2004.03833.x
MacDonald JM, Beach MG, Porpiglia E et al (2006) The drosophila cell corpse engulfment receptor draper mediates glial clearance of severed axons. Neuron 50:869–881. https://doi.org/10.1016/j.neuron.2006.04.028
Martin SM, O’Brien GS, Portera-Cailliau C, Sagasti A (2010) Wallerian degeneration of zebrafish trigeminal axons in the skin is required for regeneration and developmental pruning. Development 137:3985–3994. https://doi.org/10.1242/dev.053611
Kitay BM, McCormack R, Wang Y et al (2013) Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLDS-mediated axon protection independent of axonal mitochondria. Hum Mol Genet 22:1601–1614. https://doi.org/10.1093/hmg/ddt009
Stowers RS, Megeath LJ, Górska-Andrzejak J et al (2002) Axonal transport of mitochondria to synapses depends on Milton, a novel drosophila protein. Neuron 36:1063–1077. https://doi.org/10.1016/S0896-6273(02)01094-2
Milde S, Adalbert R, Elaman MH, Coleman MP (2015) Axonal transport declines with age in two distinct phases separated by a period of relative stability. Neurobiol Aging 36:971–981. https://doi.org/10.1016/j.neurobiolaging.2014.09.018
Valdez G, Tapia JC, Lichtman JW et al (2012) Shared resistance to aging and ALS in neuromuscular junctions of specific muscles. PLoS One 7:e34640. https://doi.org/10.1371/journal.pone.0034640
Osterloh JM, Yang J, Rooney TM et al (2012) dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science 337:481–484. https://doi.org/10.1126/science.1223899
Di Stefano M, Nascimento-Ferreira I, Orsomando G et al (2015) A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration. Cell Death Differ 22:731–742. https://doi.org/10.1038/cdd.2014.164
Di Stefano M, Loreto A, Orsomando G et al (2017) NMN deamidase delays Wallerian degeneration and rescues axonal defects caused by NMNAT2 deficiency in vivo. Curr Biol 27:784–794. https://doi.org/10.1016/j.cub.2017.01.070
Neukomm LJ, Burdett TC, Gonzalez MA et al (2014) Rapid in vivo forward genetic approach for identifying axon death genes in Drosophila. Proc Natl Acad Sci U S A 111:9965–9970. https://doi.org/10.1073/pnas.1406230111
Harwell CS, Coleman MP (2016) Synaptophysin depletion and intraneuronal Aβ in organotypic hippocampal slice cultures from huAPP transgenic mice. Mol Neurodegener 11:44. https://doi.org/10.1186/s13024-016-0110-7
Beirowski B, Berek L, Adalbert R et al (2004) Quantitative and qualitative analysis of Wallerian degeneration using restricted axonal labelling in YFP-H mice. J Neurosci Methods 134:23–35. https://doi.org/10.1016/j.jneumeth.2003.10.016
Huppke P, Wegener E, Gilley J et al (2019) Homozygous NMNAT2 mutation in sisters with polyneuropathy and erythromelalgia. Exp Neurol 320:112958. https://doi.org/10.1016/j.expneurol.2019.112958
Lukacs M, Gilley J, Zhu Y et al (2019) Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence. Exp Neurol 320:112961. https://doi.org/10.1016/j.expneurol.2019.112961
Navarro SJ, Trinh T, Lucas CA et al (2012) The C57BL/6J mouse strain background modifies the effect of a mutation in Bcl2l2. G3 (Bethesda) 2:99–102. https://doi.org/10.1534/g3.111.000778
Lunn ER, Perry VH, Brown MC et al (1989) Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur J Neurosci 1:27–33. https://doi.org/10.1111/j.1460-9568.1989.tb00771.x
Gilley J, Adalbert R, Yu G, Coleman MP (2013) Rescue of Peripheral and CNS axon defects in mice lacking NMNAT2. J Neurosci 33:13410–13424. https://doi.org/10.1523/JNEUROSCI.1534-13.2013
Ferri A, Sanes JR, Coleman MP et al (2003) Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of Motoneuron disease. Curr Biol 13:669–673. https://doi.org/10.1016/S0960-9822(03)00206-9
Gilley J, Ribchester RR, Coleman MP (2017) Sarm1 deletion, but not Wld S, confers lifelong Rescue in a Mouse Model of severe Axonopathy. Cell Rep 21:10–16. https://doi.org/10.1016/j.celrep.2017.09.027
Geisler S, Doan RA, Strickland A et al (2016) Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice. Brain 139:3092–3108. https://doi.org/10.1093/brain/aww251
Geisler S, Doan RA, Cheng GC et al (2019) Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program. JCI Insight 4:e129920. https://doi.org/10.1172/jci.insight.129920
Turkiew E, Falconer D, Reed N, Höke A (2017) Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy: deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy. J Peripher Nerv Syst 22:162–171. https://doi.org/10.1111/jns.12219
Gilley J, Mayer PR, Yu G, Coleman MP (2019) Low levels of NMNAT2 compromise axon development and survival. Hum Mol Genet 28:448–458. https://doi.org/10.1093/hmg/ddy356
Milde S, Gilley J, Coleman MP (2013) Subcellular localization determines the stability and axon protective capacity of axon survival factor Nmnat2. PLoS Biol 11:e1001539. https://doi.org/10.1371/journal.pbio.1001539
Buonvicino D, Mazzola F, Zamporlini F et al (2018) Identification of the Nicotinamide salvage pathway as a new Toxification route for antimetabolites. Cell Chem Biol 25:471–482.e7. https://doi.org/10.1016/j.chembiol.2018.01.012
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Coleman, M.P. (2020). Axon Degeneration: Which Method to Choose?. In: Babetto, E. (eds) Axon Degeneration. Methods in Molecular Biology, vol 2143. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0585-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0585-1_1
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0584-4
Online ISBN: 978-1-0716-0585-1
eBook Packages: Springer Protocols